Showing results (121-130 of 139) with videos related to
Sort By:
Pageof 14
Diabetes & Metabolism|October 1, 2008
Methodological aspects of crossover and maximum fat-oxidation rate point determinationA-S Michallet, J Tonini, J Regnier, et al.Presse Medicale (Paris, France : 1983)|March 14, 2001
[Heterogeneity of nephropathies in type 2 diabetes]D J Cordonnier, J F Cantin, N Pinel, et al.Free Radical Biology & Medicine|January 3, 2001
2'-deoxyguanosine oxidation is associated with decrease in the DNA-binding activity of the transcription factor Sp1 in liver and kidney from diabetic and insulin-resistant ratsO Ramon, H K Wong, M Joyeux, et al.Journal Des Maladies Vasculaires|January 1, 1995
[Leg ulcer and Klinefelter syndrome]B Villemur, H Truche, G Pernod, et al.Respiratory Medicine|February 6, 2016
Glucose tolerance and cardiovascular risk biomarkers in non-diabetic non-obese obstructive sleep apnea patients: Effects of long-term continuous positive airway pressureD Monneret, R Tamisier, V Ducros, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|November 10, 2001
Cysteinyl leukotrienes modulate angiotensin II constrictor effects on aortas from streptozotocin-induced diabetic ratsG Hardy, F Stanke-Labesque, M Peoc'h, et al.Journal of Endocrinological Investigation|December 26, 2025
Safety and glycemic outcomes of DBLG1 coupled to the DANA-i pump in adults and adolescents with type 1 diabetes mellitus. The SP8 trialSylvia Franc, Y Reznik, C Amadou, et al.Diabetes & Metabolism|March 24, 2009
How do patients with type 2 diabetes perceive their disease? Insights from the French DIABASIS surveyH Mosnier-Pudar, G Hochberg, E Eschwege, et al.Journal of the American Society of Nephrology : JASN|June 11, 1999
Expansion of cortical interstitium is limited by converting enzyme inhibition in type 2 diabetic patients with glomerulosclerosis. The Diabiopsies GroupD J Cordonnier, N Pinel, C Barro, et al.Diabetic Medicine : a Journal of the British Diabetic Association|June 23, 2009
Quality of life after islet transplantation: data from the GRAGIL 1 and 2 trialsP Y Benhamou, L Milliat-Guittard, A Wojtusciszyn, et al.Pageof 14